Navigation Links
A product for the detection and characterization of brucellosis launched at University of Navarra

This release is available in Spanish.

Ignacio Lpez-Goi and David Garca, researchers of the Department of Microbiology and Parasitology of the University of Navarra, have launched a new product for the detection and characterization of the Brucella bacteria, which is the causative agent for brucellosis, also known as Mediterranean fever. Their product is a commercial analysis kit, sold under the brand name Bruce-ladder, and was developed in collaboration with Ingenasa, a Madrid-based business dedicated to applied biotechnology in the areas of animal and human health and food safety.

Bruce-ladder permits the identification and differentiation of the microorganism via the amplification of sequences of specific genes using the PCR (polymerase chain reaction) technique. In order to develop this product, these microbiologists of the School of Sciences analyzed the complete sequences of the genomes of various distinct species of Brucella, which permitted them to design a system capable of differentiating them in a single test, and in less than 24 hours.

The novelty of this techniques derives from the fact that is able to distinguish all the known species of Brucella, including vaccine lines and the isolated species present in marine mammals.

A more rapid and safe analysis

"Up to now, differentiation of Brucella was only performed in central laboratories, by means of complicated biochemical and serological techniques, handling the bacteria themselves, which involved a risk for the laboratory personnel. Now, with this new molecular test, the bacteria samples can be analyzed in a simpler and more rapid manner, without having to handle the bacteria directly", as the microbiologists of the University of Navarra explained. The kit has been tested by various leading laboratories in France, Belgium and Portugal, and has been approved by the National Brucellosis Reference Center, in Granada.

Brucellosis is an infectious disease which affects both livestock and persons. According to the World Health Organization, brucellosis is part of a group of diseases, which also includes rabies and anthrax, which are considered forgotten diseases, and are strongly related to poverty. The incidence of brucellosis is very high in Africa, Asia, the Middle East and Latin America, and it is a factor in the lack of economic progress and development in these areas of the world. This new kit will aid in its diagnosis, and will permit epidemiological studies which will help to control and eventually eradicate the disease.


Contact: Garazi Andonegi
Elhuyar Fundazioa

Related medicine news :

1. London Luxury Receives Asthma & Allergy Friendly(TM) Certification for Several of Its Bedding Products
2. Jopari Ramps Up Texas eBill Production With National and Regional Carriers and Medical Billing Technology Suppliers
3. NY-Area Paramedic Wins 2007 Francis X. Hursey Award for Heroic Use of QuikClot(R) Blood Clotting Product
4. Blue Cross Blue Shield of Michigan Pioneers Total Body PPO Product
5. Scripps Florida scientists develop a process to disrupt hepatitis C virion production
6. Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition
7. National Religious Coalition Deeply Concerned by HHS Secretarys Disregard for Womens Reproductive Health
8. Schiff(R) Introduces New Supplement Products for Intestinal Health and Beauty Maintenance
9. Do bacterial combinations result in enhanced cytokine production? No!
10. Leading Health Groups Applaud Continued Efforts to Protect Public Health by Ending So-Called Theatrical Productions in Bars
11. Sergeants(R) Pet Care Products Acquires the Consumer Brand Division of Virbac Corporation
Post Your Comments:
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
(Date:11/25/2015)... ... November 25, 2015 , ... In ... nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension ... Pioneers, nominated by the public, will receive special recognition throughout 2016 as part ...
(Date:11/25/2015)... ... 25, 2015 , ... Many people know of the common symptoms of low ... dry skin. But many people who find their cholesterol levels and weight are creeping ... thyroid, especially if they don’t have any of the other symptoms. , Thyroid hormone ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bunion ... in an early celebration of the early holiday shopping season. Starting Wednesday November ... (normally $33.95 ea). Black Friday promotional pricing is in addition to any automatic ...
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 2015  Thanks to a donor with a personal ... Center,s Sister Diane Grassilli Center for Women,s Health now ... San Francisco . Fred ... with a gift of $617,320 that allowed the Center ... Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) mammography ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... new market research report "Spine Biologics Market by Product Type ... Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), ... by MarketsandMarkets, the global market was valued at $1.90 Billion ... 2020, at a CAGR of 4.4% during the forecast period ...
Breaking Medicine Technology: